相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Health technology assessment and economic evaluation: Is it applicable for the traditional medicine?
Yingyao Chen
INTEGRATIVE MEDICINE RESEARCH (2022)
Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands
Marieke Schurer et al.
VALUE IN HEALTH (2022)
Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada
Y. Y. R. Li et al.
CURRENT ONCOLOGY (2020)
The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017
Chris Skedgel et al.
PHARMACOECONOMICS (2018)
The ICER Value Framework: Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value
Steven D. Pearson
VALUE IN HEALTH (2018)
QALYs as a measure of value in cancer
Nancy J. Devlin et al.
JOURNAL OF CANCER POLICY (2017)
CADTH'S $50,000 COST-EFFECTIVENESS THRESHOLD: FACT OR FICTION?
E. A. Griffiths et al.
VALUE IN HEALTH (2016)
Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness
Mikael Svensson et al.
PHARMACOECONOMICS (2015)
Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review
Angela Rocchi et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2015)
Health outcomes in economic evaluation: the QALY and utilities
Sarah J. Whitehead et al.
BRITISH MEDICAL BULLETIN (2010)
Introduction to health economics for the medical practitioner
DP Kernick
POSTGRADUATE MEDICAL JOURNAL (2003)
Limitations of the methods used for calculating quality-adjusted life-year values
G Duru et al.
PHARMACOECONOMICS (2002)
分享论文
